Activating mutations in the extracellular domain of the melanoma inducing receptor Xmrk are tumorigenic in vivo

International Journal of Cancer

Volumn 117, Issue 5, 2005, Pages 723-729

  Winnemoeller, Dirk ^a,b   Wellbrock, Claudia ^a,c   Schartl, Manfred ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Embryonic tumors; Epidermal growth factor receptor; Medaka; Xmrk

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MELANOMA INDUCING RECEPTOR XMRK; ONCOPROTEIN; PROTEIN TYROSINE KINASE; RECEPTOR; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; EMBRYO; FAMILIAL CANCER; GENE ACTIVATION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; LATENT PERIOD; LIGAND BINDING; MELANOMA; NONHUMAN; ONCOGENE; ORYZIAS; PRIORITY JOURNAL; PROTEIN DOMAIN; STATISTICAL SIGNIFICANCE; WILD TYPE; XMRK GENE;

ANIMALS; FISH PROTEINS; MELANOMA, EXPERIMENTAL; MUTATION; ORYZIAS; RECEPTOR PROTEIN-TYROSINE KINASES;

EID: 27744551090     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.21232     Document Type: Article

References (38)

1. Blume-Jensen P, Hunter T. Oncogenic kinase signalling. Nature 2001;411:355-65.
2. Reilly JT. Receptor tyrosine kinases in normal and malignant haematopoiesis. Blood Rev 2003;17:241-8.
3. Voldborg BR, Damstrup L, Spang-Thomsen M, Poulsen HS. Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials. Ann Oncol 1997;8:1197-206.
4. Holbro T, Civenni G, Hynes NE. The ErbB receptors and their role in cancer progression. Exp Cell Res 2003;284:99-110.
5. Stove C, Stove V, Derycke L, Van Marck V, Mareel M, Bracke M. The heregulin/human epidermal growth factor receptor as a new growth factor system in melanoma with multiple ways of deregulation. J Invest Dermatol 2003;121:802-12.
6. Halaban R. The regulation of normal melanocyte proliferation. Pigment Cell Res 2000;13:4-14.
7. Adam D, Dimitrijevic N, Schartl M. Tumor suppression in Xiphophorus by an accidentally acquired promoter. Science 1993;259:816-9.
8. Volff JN, Schartl M. Sex determination and sex chromosome evolution in the Medaka, Oryzias latipes, and the platy fish, Xiphophorus maculatus. Cytogenet Genome Res 2002;99:170-77.
9. Wittbrodt J, Adam D, Malitschek B, Maueler W, Raulf F, Telling A, Robertson SM, Schartl M. Novel putative receptor tyrosine kinase encoded by the melanoma-inducing Tu locus in Xiphophorus. Nature 1989;341:415-21.
10. Gomez A, Volff JN, Hornung U, Schartl M, Wellbrock C. Identification of a second EGFR gene in Xiphophorus uncovers an expansion of the epidermal growth factor receptor family in fish. Mol Biol Evol 2004;21:266-75.
11. Kazianis S, Walter RB. Use of platy fishes and swordtails in biological research. Lab Anim (NY) 2002;31:46-52.
12. Morizot DC, McEntire BB, Della Coletta L, Kazianis S, Schartl M, Nairn RS. Mapping of tyrosine kinase gene family members in a Xiphophorus melanoma model. Mol Carcinog 1998;22:150-7.
13. Walter RB, Kazianis S. Xiphophorus interspecies hybrids as genetic models of induced neoplasia. Ilar J 2001;42:299-321.
14. Schartl M. Platy fish and swordtails: a genetic system for the analysis of molecular mechanisms in tumor formation. Trends Genet 1995;11:185-9.
15. Wellbrock C, Fischer P, Schartl M. Receptor tyrosine kinase Xmrk mediates proliferation in Xiphophorus melanoma cells. Int J Cancer 1998;76:437-42.
16. Wellbrock C, Geissinger E, Gomez A, Fischer P, Friedrich K, Schartl M. Signalling by the oncogenic receptor tyrosine kinase Xmrk leads to activation of STAT5 in Xiphophorus melanoma. Oncogene 1998;16:3047-56.
17. Wellbrock C, Weisser C, Geissinger E, Troppmair J, Schartl M. Activation of p59(Fyn) leads to melanocyte dedifferentiation by influencing MKP-1-regulated mitogen-activated protein kinase signaling. J Biol Chem 2002;277:6443-54.
18. Geissinger E, Weisser C, Fischer P, Schartl M, Wellbrock C. Autocrine stimulation by osteopontin contributes to antiapoptotic signalling of melanocytes in dermal collagen. 2002;62:4820-8.
19. Winkler C, Wittbrodt J, Lammers R, Ullrich A, Schartl M. Ligand-dependent tumor induction in medaka fish embryos by a Xmrk receptor tyrosine kinase transgene. Oncogene 1994;9:1517-25.
20. Wittbrodt J, Lammers R, Malitschek B, Ullrich A, Schartl M. The Xmrk receptor tyrosin kinase is activated in Xiphophorus malignant melanoma. EMBO J 1992;11:4239.
21. Dimitrijevic N, Winkler C, Wellbrock C, Gomez A, Duschl J, Altschmied J, Schartl M. Activation of the Xmrk prpto-oncogene of Xiphophorus by overexpression and mutational alterations. Oncogene 1998;16:1681-90.
22. Gomez A, Wellbrock C, Gutbrod H, Dimitrijevic N, Schartl M. Ligand-independent dimerization and activation of the oncogenic Xmrk receptor by two mutations in the extracellular domain. J Biol Chem 2001;276:3333-40.
23. Miller JR, Moon RT. Analysis of the signaling activities of localization mutants of beta-catenin during axis specification in Xenopus. J Cell Biol 1997;139:229-43.
24. Chen C, Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 1987;7:2745-52.
25. Malitschek B, Wittbrodt J, Fischer P, Lammers R, Ullrich A, Schartl M. Autocrine stimulation of the Xmrk receptor tyrosine kinase in Xiphophorus melanoma cells and identification of a source for the physiological ligand. J Biol Chem 1994;269:10423-30.
26. Fendly BM, Winget M, Hudziak RM, Lipari MT, Napier MA, Ullrich A. Characterization of murine monoclonal antibodies reactive to either the human epidermal growth factor receptor or HER2/neu gene product. Cancer Res 1990;50:1550-8.
27. Kirchen RV, West WR. The Japanese Medaka - Its care and development. Burlington, North Carolina: Carolina Biological Supply Company, 1976.
28. Iwamatsu T. Stages of normal development in the Medaka Oryzias latipes. Zool Sci 1994;11:825-39.
29. Winkler C, Vielkind JR, Schartl M. Transient expression of foreign DNA during embryonic and larval development of the Medaka fish (Oryzias latipes). Mol Gen Genet 1991;226:129-40.
30. Winkler C, Hong Y, Wittbrodt J, Schartl M. Analysis of heterologous and homologous promoters and enhancers in vitro and in vivo by gene transfer into Japanese Medaka (Oryzias latipes) Xiphophorus. Mol Mar Biol Biotechnol 1992;1:326-37.
31. Ekstrand AJ, Sugawa N, James CD, Collins VP. Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails. Proc Natl Acad Sci USA 1992;89:4309-13.
32. Garcia de Palazzo IE, Adams GP, Sundareshan P, Wong AJ, Testa JR, Bigner DD, Weiner LM. Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas. Cancer Res 1993;53:3217-20.
33. Wikstrand CJ, Hale LP, Batra SK, Hill ML, Humphrey PA, Kurpad SN, McLendon RE, Moscatello D, Pegram CN, Reist CJ, Traweek ST, Wong AJ, et al. Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas. Cancer Res 1995;55:3140-8.
34. Moscatello DK, Holgado-Madruga M, Godwin AK, Ramirez G, Gunn G, Zoltick PW, Biegel JA, Hayes RL, Wong AJ. Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors. Cancer Res 1995;55:5536-9.
35. Wong RW. Transgenic and knock-out mice for deciphering the roles of EGFR ligands. Cell Mol Life Sci 2003;60:113-8.
36. Muller WJ. General keynote: expression of epidermal growth factor receptor family in transgenic mouse models of human breast cancer. Gynecol Oncol 2003;88:S436; discussionS52-5.
37. Bongarzone I, Vigano E, Alberti L, Mondellini P, Uggeri M, Pasini B, Borrello MG, Pierotti MA. The Glu632-Leu633 deletion in cysteine rich domain of Ret induces constitutive dimerization and alters the processing of the receptor protein. Oncogene 1999;18:4833-8.
38. Robertson SC, Meyer AN, Hart KC, Galvin BD, Webster MK, Donoghue DJ. Activating mutations in the extracellular domain of the fibroblast growth factor receptor 2 function by disruption of the disulfide bond in the third immunoglobulin-like domain. Proc Natl Acad Sci USA 1998;95:4567-72.